This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2020.
Company Filing History:
2 out of 834,411 Years Active: 2020
Title: The Innovative Contributions of Mohammadali Khayamian in Metastasis Diagnosis
Introduction
Mohammadali Khayamian, an inventive mind based in Tehran, Iran, has made significant strides in the field of medical technology. With two notable patents to his name, his innovative approaches to diagnosing metastasis demonstrate a commitment to enhancing clinical outcomes for patients.
Latest Patents
Khayamian's most recent patents focus on a groundbreaking method and system for metastasis diagnosis and prognosis. The first patent describes a system that utilizes a bio-chip, an electrical signal extraction board, and a processor to diagnose metastasis in samples suspected of containing metastatic cells. The bio-chip features a biosensor that consists of a substrate with an array of electrodes, where Human Umbilical Vein Endothelial Cells (HUVECs) are adhered. These cells form a biological trap for capturing metastatic cells. By introducing a metastatic-suspicious sample onto the bio-chip, the system can monitor time-lapse electrical signals recorded by the processor, offering insights into the presence of metastasis.
The second patent elaborates on the method for metastasis diagnosis. It involves adhering a variety of HUVECs to the array of electrodes and measuring initial electrical signals from each electrode. After introducing a metastatic-suspicious sample onto the substrate, the system measures a series of time-lapse electrical signals to detect any changes that may indicate the presence of metastatic cells. This innovative approach leverages the condition of the electrodes, switching between an On and Off state, to identify state changes that suggest a diagnosis of metastasis.
Career Highlights
Throughout his career, Khayamian has demonstrated an exceptional ability to blend innovative technology with practical healthcare solutions. His patents signify his dedication to advancing the diagnosis and treatment of metastatic diseases, reflecting a keen understanding of both engineering and medical principles.
Collaborations
Khayamian has collaborated closely with colleagues Mohammad Abdolahad and Mohammad Saeid Nik Shoar, contributing to a dynamic research environment aimed at pushing the boundaries of how metastasis can be diagnosed and treated.
Conclusion
Mohammadali Khayamian exemplifies the spirit of innovation in the medical field through his pioneering patents that focus on the diagnosis of metastasis. His contributions not only reflect his expertise but also underscore the importance of collaborative efforts in advancing medical technology. As research continues, Khayamian's work may pave the way for more effective diagnostic treatments, benefitting countless patients in the future.